文献速递脑血管病

他汀类药物与卒中史患者脑出血风险

Statins and Risk of Intracerebral Hemorrhage in Individuals With a History of Stroke.
PubMed 文献 · Stroke · 2020-03-02

结果显示,有脑出血史者使用他汀后脑出血风险与未使用者相似,有缺血性卒中史者风险减半,未见他汀增加脑出血风险的证据。

要点

  • 有脑出血史者使用他汀后脑出血风险与未使用者相似。
  • 有缺血性卒中史者使用他汀后脑出血风险减半。
  • 结果不支持因既往卒中史而避免使用他汀。

核心结论

  • 本研究未发现他汀增加既往卒中患者脑出血风险的证据,既往缺血性卒中者风险可能更低。

主要发现

  • 随访期间,既往脑出血的他汀使用者中新发脑出血118例,既往缺血性卒中的他汀使用者中新发脑出血319例。
  • 既往脑出血者中,他汀使用者与非使用者脑出血风险相似;既往缺血性卒中者中,风险减半。
  • 上述结果在启动他汀后不同时间点一致,不能由合并起始其他药物、治疗效应稀释或健康起始者偏倚解释。

临床怎么用

  • 对于有卒中史(包括脑出血)的患者,不应仅因脑出血风险担忧而避免启动他汀治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background and Purpose- It has been suggested that statins increase the risk of intracerebral hemorrhage in individuals with a history of stroke, which has led to a precautionary principle of avoiding statins in patients with prior intracerebral hemorrhage. However, such prescribing reticence may be unfounded and potentially harmful when considering the well-established benefits of statins. This study is so far the largest to explore the statin-associated risk of intracerebral hemorrhage in individuals with prior stroke. Methods- We conducted a population-based, propensity score-matched cohort study using information from Danish national registers. We included all individuals initiating statin treatment after a first-time stroke diagnosis (intracerebral hemorrhage, N=2728 or ischemic stroke, N=52 964) during 2002 to 2016. For up to 10 years of follow-up, they were compared with a 1:5 propensity score-matched group of statin nonusers with the same type of first-time stroke. The difference between groups was measured by adjusted hazard ratios for intracerebral hemorrhage calculated by type of first-time stroke as a function of time since statin initiation. Results- Within the study period, 118 new intracerebral hemorrhages occurred among statin users with prior intracerebral hemorrhage and 319 new intracerebral hemorrhages in users with prior ischemic stroke. The risk of intracerebral hemorrhage was similar for statin users and nonusers when evaluated among those with prior intracerebral hemorrhage, and it was reduced by half in those with prior ischemic stroke. These findings were consistent over time since statin initiation and could not be explained by concomitant initiation of other medications, by dilution of treatment effect (due to changes in exposure status over time), or by healthy initiator bias. Conclusions- This large study found no evidence that statins increase the risk of intracerebral hemorrhage in individuals with prior stroke; perhaps the risk is even lower in the subgroup of individuals with prior ischemic stroke.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Ribe AR, Vestergaard CH, Vestergaard M, et al. Statins and Risk of Intracerebral Hemorrhage in Individuals With a History of Stroke. Stroke. 2020. PMID: 32114928. doi:10.1161/STROKEAHA.119.027301

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。